Navigation Links
Neuronascent Announces Collaboration with ChemRar for Characterization of Developmental Pathway Inhibitors Using Neuronascent's Neurogenesis Platform
Date:11/4/2009

;D collaboration with ChemDiv's Chemical Diversity Research Institute in Moscow to continue preclinical and clinical development for multiple cancer indications.

About Neuronascent, Inc.:

Founded in 2004 by Dr. Judith Kelleher-Andersson, Neuronascent, Inc. discovers and develops first-in-class, small-molecule therapeutics, based on the science of neurogenesis, that target depression, neurodegenerative diseases, including Alzheimer's and Parkinson's, and Down syndrome. The Company is headquartered in Clarksville, MD and has facilities in Rockville and Walkersville, MD. For additional information, please visit www.neuronascent.com.

Safe Harbor Statement

This release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as "would," "may," "will," "expects" and other terms with similar meaning. Forward-looking statements are based on current beliefs, assumptions and expectations and speak only as of the date of this release and involve risks and uncertainties that could cause actual results to differ moderately from current expectations.

SOURCE Neuronascent, Inc.


'/>"/>
SOURCE Neuronascent, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Neuronascent, Inc. Receives Multiple Fundings for Its Neurogenesis Therapeutic Programs
2. BD Announces Results for Fourth Fiscal Quarter and Full Year
3. WebMD Health Corp. Announces Intention To Commence Tender Offer To Repurchase Up To 5,700,000 Shares of its Common Stock
4. Mettler-Toledo International Inc. Announces Webcast of Presentation at Baird Industrial Conference
5. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update
6. West Announces Third Quarter 2009 Results
7. Rigel Announces Third Quarter 2009 Financial Results
8. VIVUS Announces Promotion of Peter Tam to President
9. ATS Medical Announces Third Quarter 2009 Results
10. BioVex Announces Publication of Phase 2 Melanoma Results With OncoVEX (GM-CSF) in the Journal of Clinical Oncology
11. PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015 Pepperl+Fuchs, a ... acquired MACTek Corporation, a leading provider of HART ... strategy to further extend its integrated solutions offerings ...   "We are pleased to add ... portfolio," said Jim Bolin , Pepperl+Fuchs, executive ...
(Date:8/31/2015)... , Aug. 31, 2015  Daktari Diagnostics today announced ... the United States and Canada ... test. The deal, worth up to $8.5 million over the ... the clinical validation and regulatory approval of Daktari,s HCV test. ... a point-of-care instrument that can detect low levels of virus ...
(Date:8/31/2015)... , Aug. 31, 2015  On August 5, ... Oregon denied motions to dismiss ... GALE ) and certain of its directors. The ... a "pump and dump" scheme to artificially inflate Galena,s ... while the stock price was inflated, sold massive amounts ...
Breaking Medicine Technology:Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 2Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 3Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2
... , , , SAN DIEGO, ... dedicated to developing life-saving medicines specifically designed to enhance ... through targeted oxygen delivery, today announced the initiation of ... efficacy of MP4OX treatment plus standard of care in ...
... Dec. 9 The U.S. Food and Drug Administration ... workshop series--an opportunity for biotechnology companies, pharmaceutical firms, academics ... applications for orphan status designation, under the guidance of ... The first workshop is planned for Feb. 25-26, 2010, ...
Cached Medicine Technology:Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3FDA Launches Orphan Drug Workshop at KGI 2
(Date:8/31/2015)... ... 2015 , ... Since 1946, the doctors and staff at Clifton Dental Associates ... patient arrives at the office, the staff will make them feel welcome and comfortable. ... to create a complete dental treatment plan that is unique to each smile! ...
(Date:8/31/2015)... ... August 31, 2015 , ... How can healthcare meet ... down costs? , In a commentary for The American Journal of Managed ... of “clinical efficacy,” which would bind parties together in agreements to intervene at ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Three Bakers ... visitors and retailers with even more relevant and easy-to-find information on their offering of ... “Our website has always been an important way for us to share information about ...
(Date:8/31/2015)... ... 2015 , ... Physicians’ Education Resource®, LLC (PER®) , ... Cancer Therapy for Tomorrow® meeting, is seeking abstract submissions for its 33rd ... The annual legacy meeting uses a variety of formats to educate all disciplines ...
(Date:8/31/2015)... ... August 31, 2015 , ... With baseball season in full swing, many ... will dominate the sports world. Fans desire nothing more than to see their favorite ... For children, especially those who are too young to really understand what all the ...
Breaking Medicine News(10 mins):Health News:NJ Top Dentists Presents, Clifton Dental Associates! 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 3Health News:Three Bakers Gluten Free Bakery Announces Launch of New Website 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 3Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 4Health News:New Children's Baseball Series Offers Young Fans a Way to Celebrate the World Series 2
... -- Researchers and clinicians from the Indiana University School ... distinction between lab and clinic as they debut the ... care model they developed and extensively tested over the ... care is on two groups -- patients with cognitive ...
... International Journal of Emergency Medicine, a new quarterly publication ... research developments from around the world in emergency medicine. ... be available free of charge exclusively on Springers online ... issue will be published online in March 2008. , ...
... CHICAGO, Feb. 19 Viola Startzman, M.D. of,Wooster, Ohio ... M.D. Award for,Excellence in Volunteerism. Presented by the American ... domestic physicians for,commitment to volunteer medical care to those ... Foundation presents the award in association with the,Pfizer Medical ...
... M.D.,MDiv, of Memphis, Tenn., is a recipient of the ... Medical Association (AMA) Foundation, the,award is given to domestic ... Foundation presents the award in association with the,Pfizer Medical ... Monday, March 31st, at the 2008,Excellence in Medicine Awards ...
... Murli Manohar, M.D., Ph.D.,FACP, of Canton, Ohio, is a ... by the American Medical Association (AMA) Foundation, the,award is ... U.S. The AMA Foundation presents the award in association ... be presented on Monday, March 31st, at the 2008,Excellence ...
... Choices ( http://www.nhs.uk ),the digital ,front door, to ... help people assess their drinking behaviour and improve ... Based on NHS accredited information, the drinking assessment ... seconds whether they are drinking too much, and ...
Cached Medicine News:Health News:Merging discovery with therapy: Second generation memory care debuts 2Health News:Merging discovery with therapy: Second generation memory care debuts 3Health News:Springer to launch new journal in emergency medicine 2Health News:AMA Foundation Honors Wooster, Ohio Physician for Volunteerism 2Health News:AMA Foundation Honors Memphis, Tennessee Physician for Increasing Access to Health Care in the U.S. 2Health News:AMA Foundation Honors Canton, Ohio Physician for Increasing Access to Health Care in the U.S. 2
Introducer Sheath Designed for Vascular Access...
Used to introduce balloon, electrode, closed or non-tapered end and,other catheters....
... The Driver Stent design, ... surpasses the limitations of stainless ... makes possible thinner struts, for ... support. The Driver Coronary Stent ...
The TAXUS Express Paclitaxel-Eluting Coronary Stent System is indicated for improving luminal diameter for the treatment of de novo lesions = 28 mm in length in native coronary arteries = 2.5 to = 3....
Medicine Products: